Unlock Your Cell & Gene Therapy Potential
Best-in-class development and manufacturing services for viral vectors
WHO WE ARE
Full-service Contract Development and Manufacturing Organization
Exothera is a Belgium-based CDMO delivering customized process development and GMP manufacturing services for gene therapy and viral vector-based vaccines. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide bespoke process optimization and GMP clinical and commercial production of viral vectors.
WHO WE ARE
Full-service Contract Development and Manufacturing Organization
Exothera is a Belgium-based CDMO delivering customized process development and GMP manufacturing services for gene therapy and viral vector-based vaccines. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide bespoke process optimization and GMP clinical and commercial production of viral vectors.
8,600
square meters of facilities as of July 2021
12
viral projects (AAV, adeno, etc.)
200-600
square meters fixed bed
+75
collaborators
120
million euros of funds raised by Univercells
2,000
liters scale stirred tanks
WHAT WE DO
Our Services
We support your cell and gene product development from pre-clinical to cGMP manufacturing.
WHAT WE DO
Our Services
We support your cell and gene product development from pre-clinical to cGMP manufacturing.
Designing & delivering bespoke bioproduction journeys for cell & gene therapy innovators to achieve successful market entry
WHERE WE WORK
Our Facilities
Exothera is located in the heart of Europe in Belgium (Nivelles and Jumet), just a stone’s throw from Brussels South Airport.
WHERE WE WORK
Our Facilities
Exothera is located in the heart of Europe in Belgium (Nivelles and Jumet), just a stone’s throw from Brussels South Airport.
OUR APPROACH
Our Differentiators
Tailored journey to commercial manufacturing
Flexible and highly qualitative approach to accommodate projects at all stages of development.
Continuous adoption of state-of-the-art technologies
Technology selection for cost-effective virus manufacturing.
Bioprocessing expertise
Data-driven process optimization for cost-effectiveness & high performance.